Results 261 to 270 of about 844,715 (299)

Interferon alfa, peginterferon alfa and retinopathy.

Prescrire international, 2006
(1) Retinal damage is a known adverse effect of interferon alfa. (2) Similar adverse effects have been reported with pegylated interferon alfa. The disorders generally regress within a few months, despite continued treatment.
openaire   +1 more source

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
Michael Manns, Stuart C Gordon
exaly  

Peginterferon-alfa-2a/Peginterferon-alfa-2b

Reactions Weekly, 2021
openaire   +1 more source

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Lancet, The, 2007
Bernard Escudier, Alain Ravaud, Sergio Bracarda   +2 more
exaly  

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Hakan SentÜrk, Yilmaz Cakaloglu   +2 more
exaly  

alfa

2021
openaire   +1 more source

Olipudase Alfa-rpcp

American Journal of Health-System Pharmacy, 2022
openaire   +2 more sources

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Lancet, The, 2008
Alexander Eggermont, Stefan Suciu, Mario Santinami   +2 more
exaly  

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2014
Michael Manns, Patrick Marcellin, Maria Buti   +2 more
exaly  

Efmoroctocog-alfa/Moroctocog-alfa/Octocog-alfa

Reactions Weekly
openaire   +1 more source